The Use of Complementary and Alternative Medicine among Malaysian Chronic Kidney Disease Patients
CAM in CKD patients
Vol. 14 No. 2 : 2019 (219-234)
Abstract
Many of our chronic kidney disease (CKD) patients venture into complementary and alternative medicine (CAM) to seek a cure for the disease beyond conventional management. The objective of this study was to determine the prevalence and pattern of CAM usage; and its association with the progression of CKD in our population. This was a cross-sectional survey recruited CKD patients from Universiti Kebangsaan Malaysia Medical Centre (UKMMC). Data was collected via interview using questionnaires which explore the demographics, type and pattern of CAM use. Patients’ comorbidities and serum creatinine were extracted from the medical notes to assess the association between progression of CKD and usage of CAM. Chi-square, Independent Samples t-test, Mann-Whitney U test and logistic regression were used to evaluate for an association. Three hundred and seventy two eligible patients were recruited. The prevalence of CAM use was 29% in the past year. Younger age, higher education and higher income level were associated with significantly more usage of CAM. Natural products were the commonest type of CAM used (86.1%). The belief in the effectiveness of CAM was the main reason for its uptake and about 57.8% revealed their practice to their physician. We found that the use of CAM in Malaysian CKD patients did not influence the progression of the disease.
Keywords :
alternative,
Chronic kidney disease,
complementary,
dietary supplements,
herbs,
Correspondance Address
Professor Dr. Abdul Halim Abdul Gafor. Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, 56000 Cheras, Kuala Lumpur, Malaysia. Tel: +603-9145 6091/6866 Email: halimgafor@gmail.com
References
Aboushanab, T.S., AlSanad, S. 2018. Cupping Therapy: an overview from a modern medicine perspective. J Acupunct Meridian Stud 11(3): 83-7.
Akyol, A.D., Yildirim, Y., Toker, E., Yavuz, B. 2011. The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs 20(7-8): 1035-43.
Aziz, Z., Tey, N.P. 2009. Herbal medicines: prevalence and predictors of use among Malaysian adults. Complement Ther Med 17(1): 44-50.
Baharom, N., Shamsul Azhar, S., Rotina, A.B. 2016. Prevalence of complementary alternative medicine use among patients with type ii diabetes in Negeri Sembilan, Malaysia. Med & Health 11(2): 257-66.
Barnes, P.M., Powell-Griner, E., McFann, K., Nahin, R.L. 2004. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343: 1-19
Gabardi, S., Munz, K., Ulbricht, C. 2007. A review of dietary supplement–induced renal dysfunction. Clin J Am Soc Nephrol 2(4): 757-65.
Grabe, D.W., Garrison, G.D. 2004. Comparison of natural product use between primary care and nephrology patients. Ann Pharmacother 38(7-8): 1169-72.
Hasan, S.S., Ahmed, S.I., Bukhari, N.I., Loon, W.C. 2009. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract 15(3): 152-7.
Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O’Callaghan, C.A., Lasserson, D.S., Hobbs, F.D. 2016. Global prevalence of chronic kidney disease-a systematic review and meta-analysis. Plos One 11(7): e0158765
Hooi, L.S., Ong, L.M., Ahmad, G., Bavanandan, S., Ahmad, N.A., Naidu, B.M., Mohamud, W.N., Yusoff, M.F. 2013. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int 84(5): 1034-40.
Kew, Y., Chia, Y.L., Lai, S.M., Chong, K.Y., Ho, X.L., Liew, D.W., Moy, F.M., Selvarajah S. 2015.Traditional and complementary medicine (TCM) among study population with cardiovascular risk; use and substitution for conventional medicine in Pahang, Malaysia. Med J Malaysia 70(2): 86-92.
Kleshinski, J.F., Crews, C., Fry, E., Stewart, B., Reinhart, C., Tolliver, J., Khuder, S. 2003. A survey of herbal product use in a dialysis population in northwest ohio. J Ren Nutr 13(2): 93-7.
Lee, G.B., Charn, T.C., Chew, Z.H., Ng, T.P. 2004. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract 21(6): 654-60.
Levin, A., Stevens, P.E., Bilous, R.W., Coresh, J., De Francisco, A.L.M., De Jong, P.E., Griffith, K.E., Hemmelgarn, B.R., Iseki, K., Lamb, E.J., Levey, A.S., Riella, M.C., Shlipak, M.G., Wang, H., White, C.T. Winearls, C.G. 2013. Kidney disease: improving global outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3(1): 1-150.
Lin, M.Y., Chiu, Y.W., Chang, J.S., Lin, H.L., Lee, C.T., Chiu, G.F., Kuo, M.C., Wu, M.T., Chen, H.C., Hwang, S.J. 2015. Association of prescribed chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease. Kidney Int 88(6): 1365-73.
Magro, M., Corain, L., Ferro, S., Baratella, D., Bonaiuto, E., Terzo, M., Corraducci, V., Salmaso, L., Vianello, F. 2016. Alkaline water and longevity: a murine study. Evid Based Complement Alternat Med 2016: 1-6.
Molassiotis, A., Fernández-Ortega, P., Pud, D., Ozden, G., Scott, J.A., Panteli, V., Margulies, A., Browall, M., Magri, M., Selvekerova, S., Madsen, E., Milovics, L., Bruyns, I., Gudmundsdottir, G., Hummerston, S., Ahmad, A.M., Platin, N., Kearney, N., Patiraki, E. 2005. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16(4): 655-63.
NCCIH. Complementary, Alternative, or Integrative Health: What’s In a Name? https://nccih.nih.gov/health/integrative-health [27 January 2019].
Ni, H., Simile, C., Hardy, A.M. 2002. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 40(4): 353-8.
Osman, N.A., Hassanein, S.M., Leil, M.M., NasrAllah, M.M. 2015. Complementary and alternative medicine use among patients with chronic kidney disease and kidney transplant recipients. J Ren Nutr 25(6): 466-71.
Pavlovi, N.M. 2013. Balkan endemic nephropathy-current status and future perspectives. Clin Kidney J 6(3): 257-65.
Peltzer, K., Pengpid, S., Puckpinyo, A., Yi, S., Anh le, V. 2016. The utilization of traditional, complementary and alternative medicine for non-communicable diseases and mental disorders in health care patients in Cambodia, Thailand and Vietnam. BMC Complement Altern Med 16: 92
Remli, R., Chan, S.C. 2003. Use of complementary medicine amongst diabetic patients in a public primary care clinic in Ipoh. Med J Malaysia 58(5): 688-93.
Siti, Z.M., Tahir, A., Farah, A.I., Fazlin, S.M., Sondi, S., Azman, A.H., Maimunah, A.H., Haniza, M.A., Siti Haslinda, M.D., Zulkarnain, A.K., Zakiah, I., Zaleha, W.C. 2009. Use of traditional and complementary medicine in malaysia: a baseline study. Complement Ther Med 17(5-6): 292-9.
Tangkiatkumjai, M., Boardman, H., Praditpornsilpa, K., Walker, D.M. 2013. Prevalence of herbal and dietary supplement usage in thai outpatients with chronic kidney disease: a cross-sectional survey. BMC Complement Altern Med 13: 153.
Tangkiatkumjai, M., Boardman, H., Praditpornsilpa, K., Walker, D.M. 2015. Association of herbal and dietary supplements with progression and complications of chronic kidney disease: a prospective cohort study. Nephrology 20(10): 679-87.
Vamenta-Morris, H., Dreisbach, A., Shoemaker-Moyle, M., Abdel-Rahman, E.M. 2014. Internet claims on dietary and herbal supplements in advanced nephropathy: truth or myth. Am J Nephrol 40(5): 393-8.
Wu, F.L., Chen, Y.M., Lai, T.S., Shen, L.J., Ho, Y.F., Lee, Y.T., Wu, M.S., Lin, S.L., Wu, K.D. 2012. Does chinese herb nephropathy account for the high incidence of end-stage renal disease in Taiwan? Nephron Clin Pract 120(4): c215-22.
Zollman, C., A. Vickers. 1999. ABC of complementary medicine: what is complementary medicine? BMJ 319(7211): 693-6.
